Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accomplished, accurately, accuse, agreed, antidepressant, arrive, asserted, assumption, attempt, attrition, awaiting, award, breakthrough, budget, budgeted, bulk, Bush, buyer, calendar, card, cardiovascular, Carolina, center, chemistry, clarification, Clinton, combinatorial, compensatory, contesting, coordinated, counsel, country, Creation, deficit, denied, Denmark, destroyed, diabetic, directed, discontinue, distributor, Elanco, encouraged, endocrine, equipment, eventually, evolved, excellence, expanded, fill, Finland, flawed, floating, footnote, force, foreseeable, freeze, function, German, grew, halting, hospital, HSR, improperly, inadequately, inception, inflammation, injunctive, injury, insomnia, Inspector, insulin, Iowa, IV, judgment, KGaA, Laboratory, lag, larger, largest, lease, legislation, legislatively, leverage, lifesaving, limitation, locally, Lonza, maintain, mandated, marketplace, maximize, maximum, Merck, mission, modest, molecule, month, narrowed, neuropathic, neuropathy, neuroscience, noncash, noncurrent, nonqualified, norepinephrine, offering, OIG, open, organization, pain, painful, Park, pattern, people, peripheral, persist, personal, personnel, plc, posting, potent, predominately, produce, publicly, punitive, quantify, raloxifene, redeem, regional, registry, regularly, reinvest, reorganize, repatriated, repatriation, restricted, revised, RTP, running, screening, shipped, side, speculative, standard, statutory, Steering, stronger, Sweden, temporary, termination, testing, title, tolling, Trade, trend, Triangle, underwriting, unenforceable, validity, weaker, withdrawing, world
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10 2002 Lilly Stock Plan
- 11 Statement Re: Computation of Earnings Per Share
- 12 Statement Re: Computation of Ratio of Earnings to Fixed Charges
- 31.1 Certification of Sidney Taurel, Chairman, President and CEO
- 31.2 Certification of Charles E. Golden, Executive Vice President and CFO
- 32 Section 1350 Certification
- 99 Cautionary Statement
LLY similar filings
Filing view
External links
EXHIBIT 32. Section 1350 Certification
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Eli Lilly and Company, an Indiana corporation (the “Company”), does hereby certify that, to the best of his knowledge:
The Quarterly Report on Form 10-Q for the quarter ended September 30, 2004 (the “Form 10-Q”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date November 1, 2004 | /s/ Sidney Taurel | |
Sidney Taurel | ||
Chairman of the Board, President, and | ||
Chief Executive Officer | ||
Date November 1, 2004 | /s/ Charles E. Golden | |
Charles E. Golden | ||
Executive Vice President and | ||
Chief Financial Officer |